Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneeth Iyengar

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Cancer Informatics|February 27, 2013
Design of an expert system for mitigating trace element toxicity in cancer risk managementP T Krishna Kumar, P T Vinod, Vir V Phoha, et al.
Translational Lung Cancer Research|August 25, 2021
Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative reviewMichael C Tjong, Alexander V Louie, Puneeth Iyengar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerNathan A Cannon, Jeffrey Meyer, Puneeth Iyengar, et al.
Journal of Cell Science|April 13, 2006
Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cellRoberto Lara-Lemus, Ming Liu, Mark D Turner, et al.
Clinical Genitourinary Cancer|May 22, 2019
Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of TestisArthi Satyanarayan, Ryan Mooney, Raj R Bhanvadia, et al.
British Journal of Cancer|May 26, 2026
Beyond borders: advancing oncology trialsMilit S Patel, Jeffrey Shi Kai Chan, Nina N Sanford, et al.
Journal of General Internal Medicine|March 31, 2025
Disparities in Receipt of Chemotherapy at the End of Life among Patients with NSCLCKhushi Kohli, Stephanie Wang, Shriya Garg, et al.
JTO Clinical and Research Reports|April 25, 2023
Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV NSCLC: A Brief ReportSantiago Olaechea, Alison Liu, Brandon Sarver, et al.
JAMA Network Open|June 15, 2026
Futile Radiotherapy for Patients With Cancer Near the End of LifeAlok Deshane, Morgan Freret, Victoria S Brennan, et al.
Frontiers in Oncology|July 11, 2022
Primary Tumor Fluorine-18 Fluorodeoxydglucose (<sup>18</sup>F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse SurvivalSantiago Olaechea, Bhavani S Gannavarapu, Christian Alvarez, et al.
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Cancer Informatics|February 27, 2013
Design of an expert system for mitigating trace element toxicity in cancer risk managementP T Krishna Kumar, P T Vinod, Vir V Phoha, et al.
Translational Lung Cancer Research|August 25, 2021
Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative reviewMichael C Tjong, Alexander V Louie, Puneeth Iyengar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2014
Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerNathan A Cannon, Jeffrey Meyer, Puneeth Iyengar, et al.
Journal of Cell Science|April 13, 2006
Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cellRoberto Lara-Lemus, Ming Liu, Mark D Turner, et al.
Clinical Genitourinary Cancer|May 22, 2019
Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of TestisArthi Satyanarayan, Ryan Mooney, Raj R Bhanvadia, et al.
British Journal of Cancer|May 26, 2026
Beyond borders: advancing oncology trialsMilit S Patel, Jeffrey Shi Kai Chan, Nina N Sanford, et al.
Journal of General Internal Medicine|March 31, 2025
Disparities in Receipt of Chemotherapy at the End of Life among Patients with NSCLCKhushi Kohli, Stephanie Wang, Shriya Garg, et al.
JTO Clinical and Research Reports|April 25, 2023
Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV NSCLC: A Brief ReportSantiago Olaechea, Alison Liu, Brandon Sarver, et al.
JAMA Network Open|June 15, 2026
Futile Radiotherapy for Patients With Cancer Near the End of LifeAlok Deshane, Morgan Freret, Victoria S Brennan, et al.
Frontiers in Oncology|July 11, 2022
Primary Tumor Fluorine-18 Fluorodeoxydglucose (<sup>18</sup>F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse SurvivalSantiago Olaechea, Bhavani S Gannavarapu, Christian Alvarez, et al.
Pageof 18